MASSDEVICE ON CALL — The FDA handed Proteus Digital Health clearance for its novel ingestible sensor, passing the product through a new medical device category.
The sensor is swallowed in a pill and powered through contact with stomach fluids. The device communicates wirelessly with a patch on the skin, which collects metrics such as heart rate, body position and activity.
The patch then relays the data to a mobile phone application, which can make the information accessible to family, caregivers and clinicians, according to a press release.
"The FDA validation represents a major milestone in digital medicine," Scripps Research Institute genomics professor Dr. Eric Topol said in prepared remarks. "Directly digitizing pills, for the first time, in conjunction with our wireless infrastructure, may prove to be the new standard for influencing medication adherence and significantly aid chronic disease management."
Heart CTs may provide faster, more accurate chest emergency assessment
Adding computer tomography scans to existing standards for emergency care may help healthcare providers more quickly diagnose heart attacks in patients complaining of chest pain.
Dendreon cuts 600 jobs, closes plant as sales disappoint
Cancer immunotherapy products maker Dendreon will lay off 600 full-time contractors and shutter its Morris Plains, N.J., factory in hopes of saving $150 million a year in costs as the biotech products company’s sales slide.
CareFusion updates on EnVe ventilator recall
Medical device company CareFusion provided an update on its recall of EnVe ventilators, which were pulled off of shelves over concerns that the devices may leak. The FDA dubbed the measure Class I, the most serious type of recall.
10 milestones in spinal devices
Beckers Orthopedic & Spine highlights 10 important milestones in spinal devices and medical device companies, including Medtronic’s (NYSE:MDT) global launch of the expanded CD Horizon Solera 5.5/6.0 system and Precision Spine’s $72 million buyout of Precision Medical of Mississippi.